ROCÍO
GARCÍA CARBONERO
Profesora asociada de Ciencias de la Salud
Dana–Farber Cancer Institute
Boston, Estados UnidosPublicaciones en colaboración con investigadores/as de Dana–Farber Cancer Institute (5)
2020
-
Neutropenia and survival outcomes in metastatic colorectal cancer patients treated with trifluridine/tipiracil in the RECOURSE and J003 trials
Annals of Oncology, Vol. 31, Núm. 1, pp. 88-95
2018
-
Telotristat ethyl in carcinoid syndrome: Safety and efficacy in the TELECAST phase 3 trial
Endocrine-Related Cancer, Vol. 25, Núm. 3, pp. 309-322
2017
-
Proxies of quality of life in metastatic colorectal cancer: Analyses in the RECOURSE trial
ESMO Open, Vol. 2, Núm. 5
2015
-
Randomized trial of TAS-102 for refractory metastatic colorectal cancer
New England Journal of Medicine, Vol. 372, Núm. 20, pp. 1909-1919
2002
-
Pharmacokinetics of ecteinascidin 743 administered as a 24-h continuous intravenous infusion to adult patients with soft tissue sarcomas: Associations with clinical characteristics, pathophysiological variables and toxicity
Cancer Chemotherapy and Pharmacology, Vol. 50, Núm. 4, pp. 309-319